|
|||||
|
|
Genomics and the second golden era of cancer drug development |
|
| Authors: | Workman Paul |
| Affiliation: | Cancer Research UK Centre for Cancer Therapeutics, Sutton, UK. paul.workman@icr.ac.uk |
| Abstract: | The first golden era of cancer drug development was initiated in the 1940s and gave rise to the cytotoxic agents that dominate current cancer medicine. The second golden era is now underway in which cancer genomics will direct drug development. |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |